Stock movers: Hess, Chevron, Roivant Sciences, Harpoon Therapeutics

日本 ニュース ニュース

Stock movers: Hess, Chevron, Roivant Sciences, Harpoon Therapeutics
日本 最新ニュース,日本 見出し
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

Hess Corp. Harpoon Therapeutics, Chevron, Pfizer, Roivant Sciences and Great Ajax were on the move.

Hess Corp. stock HES, -1.84% rose 3% to $167.48 after Chevron said it would buy the company for $53 billion, or $171 per share, in stock. Chevron stock CVX, -1.34% fell by 2%.

Harpoon Therapeutics stock HARP, +18.42% rose 38% as the biotech said its lung cancer drug showed “promising” antitumor activity and tolerability profile in a Phase 1/2 clinical trial. Roivant Sciences shares ROIV, -1.13% rose 14% as Roche said it would buy Telavant Holdings that Roivant owns with Pfizer for as much as $7.25 billion. Roivant is the 75% owner of the company that was only formed last year. Pfizer shares rose 0.5%, while Roche was steady in Swiss trade.Great Ajax AJX, +0.31%, a real-estate investment trust, saw its stock drop by 18% after the proposed buyout by Ellington Financial fell through.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

MarketWatch /  🏆 3. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Chevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease...
続きを読む »

Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln DealRoche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln DealBy Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion that will give it...
続きを読む »

Roche to Buy Telavant from Roivant Sciences, Pfizer for $7.1 BillionRoche to Buy Telavant from Roivant Sciences, Pfizer for $7.1 BillionIt will buy immunology company Telavant Holdings from Roivant Sciences and Pfizer.
続きを読む »

Chevron to Buy Hess for $53 BillionChevron to Buy Hess for $53 BillionThe company said it would buy Hess in an all-stock deal worth $53 billion, in the latest sign of consolidation in an oil-and-gas industry flush with cash.
続きを読む »

Chevron to buy Hess Corp for $53 billion in stockChevron to buy Hess Corp for $53 billion in stockChevron to buy Hess Corp for $53 billion in stock
続きを読む »

Chevron to buy Hess Corp for $53 billion in all-stock dealChevron to buy Hess Corp for $53 billion in all-stock dealChevron said on Monday it will buy smaller rival Hess in a $53-billion all-stock deal. Chevron is offering $171 for every Hess share, implying a premium of…
続きを読む »



Render Time: 2025-02-27 08:48:12